全球細胞治療製造市場按治療類型、技術類型、製造目的、應用和地區分類

2025 年全球細胞治療製造市場規模預估為 56.5 億美元，預計到 2032 年將達到 151.4 億美元，2025 年至 2032 年的複合年成長率為 15.1%。

圖。

近年來，由於心臟疾病等慢性疾病的發生率不斷上升，全球細胞療法製造市場經歷了顯著成長。與傳統藥物相比，細胞療法是多種疾病的更有效的治療選擇。在預計預測期內，細胞治療製造技術的進步和政府對細胞研究的支持（尤其是美國和歐洲的政府支持）將推動市場成長。然而，開發和製造細胞療法的高成本可能會阻礙市場成長。

市場動態：

全球細胞治療製造市場的成長受到心臟疾病等慢性疾病日益普及的推動。細胞治療製造技術的進步使得高效、大規模生產成為可能，推動了市場成長。各主要市場的政府都透過資金補助和監管指南支持以細胞為基礎的研究，這為市場參與者創造了機會。然而，從實驗室到商業化的細胞療法開發高成本可能會阻礙市場成長。參與企業需要大量的資本投入，這阻礙了市場的成長。細胞處理專家的短缺也阻礙了市場的成長。公司之間持續的併購為近期提供了潛在的成長機會。

本研究的主要特點

• 本報告對全球細胞治療製造市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
• 它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 全球細胞治療製造市場的主要企業根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行分析。
• 主要企業包括藥明康德、Lonza、Merck KGaA、Takara Bio、住友大日本製藥、富士FUJIFILM Holdings、賽默飛Astellas製藥、OXGENE、Cytiva、Exothera、Charles River Laboratories、Cell Therapies Pty Ltd、Bio-Techne 和 Catalent, Inc.
• 本報告的見解可以幫助負責人和企業經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球細胞療法製造市場迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過用於分析全球細胞治療製造市場的各種策略矩陣來簡化決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 主要進展
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第 4 章。

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 全球細胞治療製造市場按治療類型分類（2020-2032 年）

• 同種異體細胞治療
• 自體細胞治療

6. 全球細胞治療製造市場按技術類型分類（2020-2032 年）

• 體細胞技術
• 細胞永生化技術
• 病毒載體技術
• 基因組編輯技術
• 細胞可塑性技術
• 3D 技術

7. 全球細胞治療製造市場依製造目的分類（2020-2032 年）

• 臨床
• 商業的
• 臨床前

8. 全球細胞治療製造市場按應用分類（2020-2032 年）

• 肌肉骨骼
• 心血管
• 胃腸道
• 神經系統
• 腫瘤學
• 皮膚科
• 其他

9. 全球細胞治療製造市場（按地區分類） (2020-2032)

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第10章 競爭格局

• 公司簡介
  • WuXi AppTec, Inc.
  • Lineage Cell Therapeutics, Inc.
  • Healios Ltd.
  • Lonza
  • Merck KGaA
  • Takara Bio Inc.
  • Sumitomo Dainippon Pharma Co., LTD.
  • Fujifilm Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Astellas Pharma Inc.
  • OXGENE
  • Cytiva
  • Exothera
  • Charles River Laboratories
  • Cell Therapies Pty Ltd
  • Bio-Techne
  • Catalent, Inc

第 11 章 分析師建議

• 命運之輪
• 分析師觀點
• Coherent Opportunity Map（COM）

第 12 章參考文獻與調查方法

• 參考
• 調查方法

Global Cell Therapy Manufacturing Market is estimated to be valued at USD 5.65 Bn in 2025 and is expected to reach USD 15.14 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2032.

Figure. Cell Therapy Manufacturing Market Share (%), By Region 2025

Global cell therapy manufacturing market has been witnessing significant growth in the recent years, owing to growing prevalence of chronic diseases such as cancer and cardiac disorders. Cell therapies are more effective treatment options for various conditions as compared to traditional drugs. The advancement in cell therapy manufacturing technology and government support for cell-based research especially in the U.S. and Europe are projected to drive the market growth during the forecast period. However, high costs associated with cell therapy development and manufacturing can hamper the market growth.

Market Dynamics:

Global cell therapy manufacturing market growth is driven by growing prevalence of chronic diseases such as cancer and cardiac disorders. Advancements in cell therapy manufacturing technologies enable efficient and large-scale production, and this drives the market growth. Various governments across major markets are supporting cell-based research through funding and regulatory guidelines, and this offers opportunities for market players. However, high costs associated with cell therapy development from laboratory to commercialization can hamper the growth of market. Market players require huge capital investments, and this hampers the market growth. Lack of skilled professionals for cell processing also hampers the market growth. Ongoing mergers and acquisitions among players provides potential growth opportunities in the near future.

Key Features of the Study:

• This report provides an in-depth analysis of the global cell therapy manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cell therapy manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes WuXi AppTec, Inc., Lineage Cell Therapeutics, Inc., Healios Ltd. , Lonza, Merck KGaA, Takara Bio Inc., Sumitomo Dainippon Pharma Co., LTD., Fujifilm Holdings Corporation, Thermo Fisher Scientific, Inc., Astellas Pharma Inc., OXGENE, Cytiva, Exothera, Charles River Laboratories, Cell Therapies Pty Ltd, Bio-Techne, Catalent, Inc
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global cell therapy manufacturing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell therapy manufacturing market.

Detailed Segmentation-

• By Therapy Type:
  • Allogeneic Cell Therapy
  • Autologous Cell Therapy
• By Technology Type:
  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Cell Plasticity Technology
  • 3D Technology
• By Manufacturing Purpose:
  • Clinical
  • Commercial
  • Pre-clinical
• By Application:
  • Musculoskeletal
  • Cardiovascular
  • Gastrointestinal
  • Neurological
  • Oncology
  • Dermatology
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • WuXi AppTec, Inc.
  • Lineage Cell Therapeutics, Inc.
  • Healios Ltd.
  • Lonza
  • Merck KGaA
  • Takara Bio Inc.
  • Sumitomo Dainippon Pharma Co., LTD.
  • Fujifilm Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Astellas Pharma Inc.
  • OXGENE
  • Cytiva
  • Exothera
  • Charles River Laboratories
  • Cell Therapies Pty Ltd
  • Bio-Techne
  • Catalent, Inc

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapy Type
  • Market Snapshot, By Technology Type
  • Market Snapshot, By Manufacturing Purpose
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Cell Therapy Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Cell Therapy Manufacturing Market, By Therapy Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Allogeneic Cell Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Autologous Cell Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cell Therapy Manufacturing Market, By Technology Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Somatic Cell Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell Immortalization Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Viral Vector Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genome Editing Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell Plasticity Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 3D Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cell Therapy Manufacturing Market, By Manufacturing Purpose, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Clinical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Commercial
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pre-clinical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cell Therapy Manufacturing Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Musculoskeletal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiovascular
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gastrointestinal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oncology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dermatology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Cell Therapy Manufacturing Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

• Company Profiles
  • WuXi AppTec, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Lineage Cell Therapeutics, Inc.
  • Healios Ltd.
  • Lonza
  • Merck KGaA
  • Takara Bio Inc.
  • Sumitomo Dainippon Pharma Co., LTD.
  • Fujifilm Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Astellas Pharma Inc.
  • OXGENE
  • Cytiva
  • Exothera
  • Charles River Laboratories
  • Cell Therapies Pty Ltd
  • Bio-Techne
  • Catalent, Inc

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact